Cambridge Investment Research Advisors, Inc. I Bio, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022
SELL
$0.55 - $1.04 $8,153 - $15,418
-14,825 Closed
0 $0
Q3 2021

Nov 02, 2021
BUY
$1.06 - $1.52 $15,714 - $22,534
14,825 New
14,825 $15,000
Q2 2021

Aug 10, 2021
SELL
$1.22 - $1.65 $13,755 - $18,603
-11,275 Closed
0 $0
Q1 2021

May 07, 2021
BUY
$1.18 - $2.62 $13,304 - $29,540
11,275 New
11,275 $17,000

About iBio, Inc.

IBIO Quotes by TradingView
  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email